Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
147.50    -1.50 (-1.01%)
Bid:
145.00
Ask:
150.00
Spread: 5.00 (3.448%)
Market Cap: £45.56m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Trading Update

17 Aug 2022 07:00

RNS Number : 2391W
Gattaca PLC
17 August 2022
 

17 August 2022

 

Gattaca plc

 

("Gattaca" or "the Group")

 

Trading Update for the 12 months ended 31 July 2022

Trading in line

 

 

Gattaca plc ("Gattaca" or the "Group"), the specialist Engineering and Technology staffing solutions business, today provides the following trading update for the 12 months ended 31 July 2022.

 

NFI & Profit performance

Group continuing NFI1 expected to be £44.0m (FY21: £42.1m), an increase of 4% YoY

 

NFI mix split between Contract 69% / Permanent 31% (FY21: 75%:25%). Contract NFI was down c3% YoY due to three client losses in the first half. We saw strong demand for permanent recruitment within the UK, which was up 33% YoY, driven by particularly strong demand in the mobility market and professional skills

 

We continue to invest in increasing our sales headcount, which is up 7% on prior year

 

We expect our continuing underlying PBT for the full year to be in line with market consensus of break even

 

Balance Sheet

 

The Group has improved its financial position from the half year (31 January 2022: net debt £(0)m), with statutory net cash as at 31 July 2022 of £12m (31 July 2021: net cash £14m). During the financial year the Group repaid deferred VAT of £5.6m, which was the key driver of the decrease in cash from the prior year.

 

Full year results

The Group expects to announce its full year results for the 12 months to 31 July 2022 on Thursday 3 November 2022.

 

 

Matthew Wragg, Chief Executive Officer said:

"We are pleased with the performance of the Group through the second half of the year and importantly the speed in which the business is embracing our four strategic pillars; increased external focus, improved culture, operational performance, and cost rebalancing. We have established a solid foundation from which we can grow, leaving us well placed as we enter our new financial year, which has started well.

"We are mindful of the current macro-economic conditions as we continue to see robust demand in our key markets. There remains a shortage of candidates which plays to our key strength of deep knowledge and understanding of our sectors and niche STEM skills. We remain confident that the long-term fundamentals in our core STEM markets provide an exciting future for the business as it returns to growth."

 

 

 

1. NFI is calculated as revenue less contractor payroll costs

 

 

For further information please contact:

Gattaca plc

+44 (0) 1489 898989

Matthew Wragg, Chief Executive Officer

Oliver Whittaker, Chief Financial Officer

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

Robert Morton

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Jos Bieneman

Ellen Wilton

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDQLFFLVLEBBL
Date   Source Headline
14th May 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 20267:00 amRNSInterim Results
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Feb 20267:00 amRNSTrading Update
31st Dec 20257:00 amRNSDirector/PDMR dealing
31st Dec 20257:00 amRNSDirector/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
16th Dec 202512:19 pmRNSExercise of Options and Director/PDMR Shareholding
11th Dec 20259:05 amRNSResults of Annual General Meeting
10th Nov 20257:00 amRNSAvailability of Report & Accounts and AGM Notice
23rd Oct 20257:00 amRNSFinal results for the year ended 31 July 2025
15th Oct 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
13th Oct 20252:59 pmRNSBlock Listing Six Monthly return
8th Oct 20257:00 amRNSNotice of Results
5th Aug 20257:00 amRNSTrading update and Acquisition
22nd Jul 20257:00 amRNSEBT Share Purchase Programme
21st Jul 20256:22 pmRNSExercise of Options and Director/PDMR Shareholding
2nd Apr 20252:21 pmRNSCORRECTION – Interim Results
2nd Apr 20257:00 amRNSInterim Results
1st Apr 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Feb 20257:00 amRNSTrading Update
27th Jan 20254:51 pmRNSFurther re EBT Share Purchase Programme
11th Dec 20243:59 pmRNSDirector/PDMR Shareholding
11th Dec 20242:25 pmRNSResult of AGM
11th Nov 20242:29 pmRNSAvailability of Report & Accounts and AGM Notice
30th Oct 20247:00 amRNSEBT Share Purchase Programme
24th Oct 20247:00 amRNSFinal results for the year ended 31 July 2024
1st Oct 20247:00 amRNSBlock listing Six Monthly Return
15th Aug 20247:00 amRNSTrading Update for the year ended 31 July 2024
16th Jul 202410:36 amRNSDirector/PDMR Share Purchase
11th Jul 202411:13 amRNSExercise of Options
1st Jul 20247:00 amRNSNominated Adviser and Broker
16th Apr 20247:00 amRNSInterim Results
2nd Apr 20247:00 amRNSBlock listing six monthly return
15th Feb 20247:00 amRNSTrading Update
25th Jan 20247:00 amRNSExercise of Options
6th Dec 20235:07 pmRNSDirector/PDMR Shareholding
6th Dec 20234:51 pmRNSResults of Annual General Meeting
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.